Covid-19 Clinical Trials in Central Illinois

(309) 291-0585

info@kochresearch.com

COVID-19 Clinical Trial in Central Illinois

This COVID-19 clinical study aims to assess the safety, effectiveness, and tolerability of a novel investigational drug for individuals affected by COVID-19.

By thoroughly examining these aspects, the study seeks to provide valuable insights into how this new drug performs over time in managing and mitigating the symptoms of COVID-19. Ultimately, this research will contribute to improved care and outcomes for individuals affected by the virus.

Eligibility Criteria

Age: 50 years or older
Gender: Male & Female
Condition: Current COVID-19 Diagnosis
Status: Recruiting

Disclaimer
**Participation in the study, including all procedures and treatment including the investigational drug, is provided at no cost, and having insurance is not required**

Facebook

This field is for validation purposes and should be left unchanged.

First Name(Required)

Last Name(Required)

Phone Number(Required)

Email(Required)

Best time to call

How did you find us?

Specific Interest(Required)

COVID-19 treatment clinical trial (currently enrolling)

Consent

"By checking this box, you consent to receive SMS messages from Koch Research Institute regarding clinical trial opportunities, appointment reminders, and relevant updates. Message and data rates may apply. Message frequency may vary. You can reply STOP at any time to unsubscribe or HELP for assistance. Please review our Privacy Policy and Terms and Conditions for more information."

COVID-19 Clinical Trial in Central Illinois

Eligibility Criteria

Contact us for new patient appointments.